8-K: CareTrust REIT Reports Strong Fourth Quarter and Full Year 2023 Results, Announces Positive 2024 Outlook

CareTrust REIT announced solid financial results for Q4 and full year 2023, highlighted by strong investment activity and a positive outlook for 2024.

Summary

• CareTrust REIT reported 100% contractual rent collection for the fourth quarter, bringing the full year collection rate to 97.7%.
• The company's net income for the quarter was $26.3 million, or $0.22 per share, and normalized FFO was $43.4 million, or $0.36 per share.
• For the full year, net income was $53.7 million, or $0.50 per share, and normalized FFO was $149.6 million, or $1.41 per share.
• CareTrust invested $43.2 million in the fourth quarter and $288.1 million for the full year, with estimated stabilized yields of 11.4% and 9.8%, respectively.
• The company settled 14.6 million shares under its ATM program in Q4, generating gross proceeds of $319.9 million.
• CareTrust's net debt to annualized normalized run rate EBITDA was 1.4x, below the target range of 4.0x to 5.0x.
• As of the report date, the company had no borrowings outstanding on its $600 million revolving credit line and approximately $220 million in cash on hand.
• The company has an investment pipeline of $250 million and expects a strong year for new investments in 2024.
• CareTrust issued 2024 guidance, projecting net income of approximately $1.02 to $1.04 per share, normalized FFO of $1.43 to $1.45 per share, and normalized FAD of $1.47 to $1.49 per share.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, strategic investments, and a healthy balance sheet. The company's management is optimistic about future growth, and the financial metrics are generally favorable. However, there are some risks associated with the healthcare sector and the company's tenants, which temper the overall sentiment.

Positives

• CareTrust achieved full contractual rent collection in Q4 2023, demonstrating strong tenant performance.
• The company's investment activity in 2023 was robust, with $288.1 million deployed at a solid 9.8% stabilized yield.
• CareTrust successfully paid off its $600 million line of credit and ended the year with a strong cash balance of approximately $294 million.
• The company's leverage is well below its target range, indicating a healthy financial position.
• The 2024 guidance suggests continued growth and profitability.
• The company has a substantial investment pipeline of $250 million, indicating future growth potential.
• The company has a strong cash position with $220 million on hand and no debt maturities prior to 2026.

Negatives

• The company's net income for the full year 2022 was a loss of $7.506 million, compared to a profit of $53.735 million in 2023.
• The company has a provision for loan losses of $3.844 million for the year ended December 31, 2023.
• The company has an impairment of real estate investments of $36.301 million for the year ended December 31, 2023.

Risks

• The company's future performance is subject to the ability and willingness of its tenants to meet their lease obligations.
• There is a risk of additional impairment charges related to assets held for sale if they cannot be sold at expected prices.
• Healthcare reform legislation, including minimum staffing requirements, could impact the operating results of tenants.
• The company's performance is subject to the ability of tenants to comply with applicable laws and regulations.
• The company's performance is subject to the ability of tenants to renew leases and the ability to reposition properties if leases are not renewed.
• The company's performance is subject to the availability of suitable tenants and acquisition opportunities.
• The company's performance is subject to the ability to generate sufficient cash flows to service its debt.
• The company's performance is subject to access to debt and equity capital markets and fluctuating interest rates.
• Public health crises, such as COVID-19, could impact the company's operations.
• The company's performance is subject to the ability to retain key management personnel.
• The company's performance is subject to the ability to maintain its status as a real estate investment trust (REIT).
• Changes in U.S. tax law and other state, federal or local laws could impact the company's performance.
• Other risks inherent in the real estate business, including potential liability relating to environmental matters and illiquidity of real estate investments, could impact the company's performance.

Future Outlook

CareTrust expects 2024 to be a strong year for new investments, with an investment pipeline of approximately $250 million. The company has issued guidance for 2024, projecting growth in net income, normalized FFO, and normalized FAD.

Management Comments

• Dave Sedgwick, President and CEO, stated that 2023 was a great year for the company on all fronts.
• Mr. Sedgwick noted the company invested $288 million at a stabilized yield of 9.8% and expanded operator relationships.
• Mr. Sedgwick highlighted the payoff of the $600 million line of credit and ending the year with approximately $294 million of cash.
• Mr. Sedgwick expects 2024 to be a strong year for new investments, assuming the business environment remains steady.
• Bill Wagner, CFO, reported the financial results for the fourth quarter and full year 2023.
• Mr. Wagner stated that the company has no borrowings outstanding on its $600 million revolving credit line and approximately $220 million in cash on hand.
• Mr. Wagner noted that the company has $274.1 million in available authorization remaining on its at-the-market equity program.
• Mr. Wagner stated that the company continues to have a wide range of capital options for funding its opportunistic growth strategy.
• Mr. Wagner provided the 2024 guidance for net income, normalized FFO, and normalized FAD.

Industry Context

This announcement reflects a positive trend in the healthcare REIT sector, with CareTrust demonstrating strong operational performance and strategic growth. The company's focus on skilled nursing and seniors housing aligns with the increasing demand for these services due to the aging population. The company's ability to maintain high rent collection rates and secure favorable investment yields positions it well within the competitive landscape.

Comparison to Industry Standards

• CareTrust's 97.7% rent collection rate for the year is strong, indicating effective tenant management and lease structures, and is comparable to other high-performing healthcare REITs such as Omega Healthcare Investors (OHI) and National Health Investors (NHI).
• The company's net debt to annualized normalized run rate EBITDA of 1.4x is conservative compared to the industry average, which typically ranges from 4x to 6x, suggesting a lower risk profile than peers like Sabra Health Care REIT (SBRA) and Medical Properties Trust (MPW).
• CareTrust's investment yield of 9.8% for the year is competitive, reflecting the company's ability to source attractive deals in the healthcare real estate market, and is comparable to the yields achieved by Welltower (WELL) and Ventas (VTR) in their respective portfolios.
• The company's 2024 guidance for normalized FFO per share of $1.43 to $1.45 is in line with the growth expectations for the sector, indicating a stable outlook for the company's financial performance, and is comparable to the guidance provided by LTC Properties (LTC) and Healthcare Trust of America (HTA).
• The company's dividend payout ratio of 76% on normalized FAD is within the typical range for REITs, balancing shareholder returns with reinvestment in the business, and is comparable to the payout ratios of other healthcare REITs such as Physicians Realty Trust (DOC) and Universal Health Realty Income Trust (UHT).

Stakeholder Impact

• Shareholders will benefit from the company's strong financial performance and dividend payout.
• Employees will benefit from the company's continued growth and stability.
• Tenants will benefit from the company's strong financial position and ability to support their operations.
• Creditors will benefit from the company's low leverage and strong cash position.
• Customers will benefit from the company's continued investment in healthcare properties.

Next Steps

• The company will hold a conference call on February 9, 2024, to discuss the results.
• The company will continue to pursue new investment opportunities, with a focus on its $250 million pipeline.
• The company will execute its 2024 guidance, focusing on growth in net income, normalized FFO, and normalized FAD.

Key Dates

Keywords

REIT, Healthcare Real Estate, Skilled Nursing, Seniors Housing, Real Estate Investment, Net Lease, FFO, FAD, EBITDA, Investments, Dividends, ATM Program